Sort
82,697 grants matching “vaccine development”
NIAID SPECIMEN REPOSITORY
$3,451,231Deborah Phippard · Precision Bioservices, Inc. · N01 · FY2017 · AI
Orthopox immunization in patients with cancer or eczema
$3,445,581Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2006 · AI
Orthopox immunization in patients with cancer or eczema
$3,444,555Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2008 · AI
Protective orthopox immunization in normals and patients with cancer or eczema
$3,444,553Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2007 · AI
TNPRC Regional Biocontainment Laboratory Upgrade for Capacity Building
$3,442,958Jay Rappaport · Tulane University Of Louisiana · G20 · FY2022 · AI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates
$3,442,683Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2024 · AI
Identification and characterization of tau seeding and strain composition in tauopathy
$3,442,490Marc I Diamond · Ut Southwestern Medical Center · RF1 · FY2019 · AG
Emory-CDC CTU
$3,442,177Ighovwerha Ofotokun · Emory University · UM1 · FY2023 · AI
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$3,440,662Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2022 · CA
Therapeutic Monoclonal Antibodies to H5N1 Influenza
$3,435,365Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2010 · AI
B Cell Biology
$3,432,692Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Combined Approach to Broadly Protective AIDS Vaccines
$3,431,489Shiu-Lok Hu · University Of Washington · P01 · FY2006 · AI
A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes
$3,428,670David A Rasko · University Of Maryland Baltimore · U19 · FY2022 · AI
UTMB Clinical and Translational Science Award
$3,427,368Allan R. Brasier · University Of Texas Med Br Galveston · UL1 · FY2015 · TR
GENERAL CLINICAL RESEARCH CENTER
$3,425,357New York University School Of Medicine · M01 · FY2002 · RR
Synthetic DNA & Novel Env Vaccine for HIV
$3,424,516David B. Weiner · Wistar Institute · U19 · FY2016 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$3,423,644Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Orthopox immunization in patients with cancer or eczema
$3,422,012Dana-Farber Cancer Institute · U19 · FY2005 · AI
Primary Infection Resource Consortium (PIRC)
$3,420,278Susan Little · University Of California, San Diego · R24 · FY2020 · AI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates
$3,420,035Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2022 · AI
Infectious Diseases Fellowship Program
$3,418,984Christa Zerbe · National Institute Of Allergy And Infectious Diseases · ZIE · FY2022 · AI
Role of Regulatory T Cells in Parasitic Infections
$3,418,583Yasmine Belkaid · Niaid Extramural Activities · Z01 · FY2007 · AI
HIV VACCINES DESIGN & DEVELOPMENT TEAMS-PART B-THERAPEUTIC VACCINE
$3,418,543Chang Wang · · N01 · FY2007 · AI
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$3,413,667Matthias Schnell · Thomas Jefferson University · N01 · FY2022 · AI
HIV/AIDS Vaccine and Antibody Development
$3,413,428John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2019 · AI